ARS Pharmaceuticals (SPRY) Asset Utilization Ratio (2023 - 2025)
Historic Asset Utilization Ratio for ARS Pharmaceuticals (SPRY) over the last 4 years, with Q3 2025 value amounting to 0.42.
- ARS Pharmaceuticals' Asset Utilization Ratio rose 346102.42% to 0.42 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.42, marking a year-over-year increase of 346102.42%. This contributed to the annual value of 0.31 for FY2024, which is 26160863.6% up from last year.
- Latest data reveals that ARS Pharmaceuticals reported Asset Utilization Ratio of 0.42 as of Q3 2025, which was up 346102.42% from 0.35 recorded in Q2 2025.
- In the past 5 years, ARS Pharmaceuticals' Asset Utilization Ratio ranged from a high of 0.42 in Q3 2025 and a low of 0.0 during Q1 2024
- Its 4-year average for Asset Utilization Ratio is 0.09, with a median of 0.0 in 2022.
- As far as peak fluctuations go, ARS Pharmaceuticals' Asset Utilization Ratio crashed by 9821.79% in 2024, and later surged by 65948605.54% in 2025.
- ARS Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.0 in 2022, then tumbled by 97.39% to 0.0 in 2023, then skyrocketed by 251602.23% to 0.31 in 2024, then skyrocketed by 32.73% to 0.42 in 2025.
- Its last three reported values are 0.42 in Q3 2025, 0.35 for Q2 2025, and 0.29 during Q1 2025.